Citation

Kathleen M. Powis, Mauricio Pinilla, Flynn McMorrow, Alice Stek, Kristina M. Brooks, David E. Shapiro, Kevin Knowles, Ahizechukwu C. Eke, Elizabeth Greene, Allison Agwu, Lourdes Topete, Renee Browning, Nahida Chakhtoura, Priyanka Arora, Xiaoying Huang, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2026 Protocol Team. Pharmacokinetics and safety of bictegravir in pregnant and postpartum persons with HIV and their infants. Journal of Acquired Immune Deficiency Syndromes. 2025. 98: 300-307. PMID: 39813286

Citation

Tapiwa Mbengeranwa, Lauren Ziemba, Sean S. Brummel, Ben Johnston, Haseena Cassim, Gerhard Theron, Zukiswa Ngqawana, Deo Wabwire, Katie McCarthy, John Shepherd, Shahin Lockman, Lameck Chinula, Lynda Stranix-Chibanda, IMPAACT 2010/VESTED study team and investigators. Bone mineral content, growth, and renal health of infants with perinatal exposure to maternal dolutegravir vs efavirenz and tenofovir disoproxil fumarate vs tenofovir alafenamide: the randomized IMPAACT 2010 (VESTED) trial. Journal of AIDS. 2025. PMID: 40001275

Citation

Carolyn Bolton Moore, Kristin Baltrusaitis, Brookie M. Best, John H. Moye, Ellen Townley, Avy Violari, Barbara Heckman, Sarah Buisson, Rodica M. Van Solingen-Ristea, Edmund V. Capparelli, Mark A. Marzinke, Elizabeth D. Lowenthal, Shawn Ward, Chelsea Krotje, Ryan Milligan, Allison L. Agwu, Jenny Huang, Amy Cheung, Cynthia McCoig, Dwight E. Yin, Gilly Roberts, Herta Crauwels, Veerle Van Eygen, Sara Zabih, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Violet Korutaro, Aditya H. Gaur, IMPAACT 2017 Collaborators. Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2025. 12: e191-e200. PMID: 40049924

Citation

Jennifer A. Hughes, Mauricio Pinilla, Kristina M. Brooks, Ahizechukwu C. Eke, Alice Stek, Brookie M. Best, Mark Mirochnick, Renee Browning, Lubbe Wiesner, Kathleen George, Kevin Knowles, Petra De Koker, Nahida Chakhtoura, Anneke C. Hesseling, Eric Decloedt, David E. Shapiro, Marije van Schalkwyk, IMPAACT P1026s Protocol Team. Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.. Clinical Pharmacology. 2025. PMID: 40155501

Citation

Sharon Sawe, Lufina Tsirizani, Richard Court, Kamunkhwala Gausi, Asanda Poswa, Tasnim Badat, Lubbe Wiesner, Marian Loveday, Gary Maartens, Francesca Conradie, Paolo Denti. The effect of pregnancy on the population pharmacokinetics of levofloxacin in South Africans with rifampicin-resistant tuberculosis. Antimicrobial Agents and Chemotherapy. 2025. PMID: 40167446

Citation

Mark F Cotton, Patrick Jean-Philippe, Anne Coletti, Ellen G Chadwick, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Deborah Persaud, Christina Reding, Yvonne Bryson, Mary N Carrington, Bryan S Nelson, Sai Majji, Camlin Tierney, Dwight E Yin. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024. 23: 2352-3018. PMID: 38061376

Citation

Lauren Ziemba, Rebecca Zash, Lameck Chinula, Roger Shapiro, Jeffrey S A Stringer, Nahida Chakhtoura, Frances Nakayiwa, Ben Johnston, Avy Violari, Chelsea Krotje, Lee Fairlie, Katie McCarthy, Victoria Ndyanabangi, Patrick Jean-Philippe, Teacler G. Nematadzira, Paul Sax, Sherika Hanley, Judith S. Currier, Esau João, Shahin Lockman, Linda Aurpibul, VESTED Study Team, Mario Dias Correa Junior, Oranich Navanukroh, Neetal Nevrekar, Risa M. Hoffman, Gerhard Theron, Sean Brummel, Cristina Barroso Hofer. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clinical Infectious Diseases. 2024. ciae001PMID: 38180851

Citation

Sharon Nachman, Frederic Bone, Jennifer Jao, Kira Bacon, Murli Purswani, Benjamin Johnston, Allison Agwu, Christina Reding, Christy Beneri, Kathryn Kersey, Jaime G. Deville, Rita Humeniuk, Kathleen Powis, Brookie M. Best, Alice M. Stek, Mark Mirochnick, Ahizechukwu Eke, Jeremiah D. Momper, David E. Shapiro, IMPAACT 2032 Study Team, Edmund Capparelli, Elizabeth Greene, Kathleen George, Kristina M. Brooks, Dwight E. Yin, Kristin Baltrusaitis, Patrick Jean-Philippe, Diana F. Clarke, Nahida Chakhtoura. Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID: Results from IMPAACT 2032. Journal of Infectious Diseases. 2024. 230: 878-888. PMID: 38839047

Citation

Jyoti Mathad, Grace Montepiedra, Amita Gupta, Savita Pahwa, Kimberly J.S. Hjelmar, Lesley R. de Armas, Evan Goldberg, Suresh Pallikkuth. Impact of in-utero exposure to HIV and latent TB on infant humoral responses. Frontiers in Immunology. 2024. 15: 1423435. PMID: 38994354

Citation

Kevin Knowles, Lauren Ziemba, Sean Bremmel, Anne Coletti, Patrick Jean Philippe, Nahida Chakhtoura, Tichaona Vhembo, Haseena Cassim, Maxensia Owor, Lee Fairlie, Sikhulile Moyo, Violet Korutaro, Lameck Chinula, Marley D. Bishop, Shahin Lockman, Ceejay L. Boyce, Lisa M. Frenkel, Ingrid A. Beck, IMPAACT 2010 Team, Sheila M. Styrchak. Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial. Journal of International AIDS Society. 2024. 96: 385-392. PMID: 39175843